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ABSTRACT: Histopathological diagnoses of tumors in tissue biopsy after Hematoxylin and
Eosin (H&E) staining is the gold standard for oncology care. H&E staining is slow and
uses dyes, reagents and precious tissue samples that cannot be reused. Thousands of native
nonstained RGB Whole Slide Image (RWSI) patches of prostate core tissue biopsies were
registered with their H&E stained versions. Conditional Generative Adversarial Neural Net-
works (cGANs) that automate conversion of native nonstained RWSI to computational H&E
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stained images were then trained. High similarities between computational and H&E dye
stained images with Structural Similarity Index (SSIM) 0.902, Pearsons Correlation Coeffi-
cient (CC) 0.962 and Peak Signal to Noise Ratio (PSNR) 22.821 dB were calculated. A second
cGAN performed accurate computational destaining of H&E dye stained images back to
their native nonstained form with SSIM 0.9, CC 0.963 and PSNR 25.646 dB. A single-blind
study computed more than 95% pixel-by-pixel overlap between prostate tumor annotations
on computationally stained images, provided by five-board certified MD pathologists, with
those on H&E dye stained counterparts. We report the first visualization and explanation of
neural network kernel activation maps during H&E staining and destaining of RGB images
by cGANs. High similarities between kernel activation maps of computational and H&E
stained images (Mean-Squared Errors <0.0005) provide additional mathematical and mech-
anistic validation of the staining system. Our neural network framework thus is automated,
explainable and performs high precision H&E staining and destaining of low cost native
RGB images, and is computer vision and physician authenticated for rapid and accurate
tumor diagnoses.
1 INTRODUCTION
Cancer is the second leading cause of death in the United States 1. An estimated 164,690
American men were diagnosed with prostate cancer and 29,430 succumbed to the disease in 2018 1.
Survival rate for people with localized prostate cancer is above 98%, which drops to 30% when
cancer spreads to other parts of the body such as distant lymph nodes, bones or other organs 1. This
2
drop in survival rate can be prevented with early diagnosis. The current gold standard for prostate
cancer diagnosis uses dye staining of core biopsy tissue and subsequent microscopic histopatho-
logic examination by trained pathologists. Hematoxylin and Eosin (H&E) is the most widely used
dye staining method that leverages interactions of hematoxylin and eosin dyes with tissues for
visualization 2. Everyday up to three million slides are stained with this technique. Microscopic
diagnosis of tumors using H&E stained biopsy slides present challenges such as inconsistencies
introduced during tissue preparation and staining, human errors and also requires significant pro-
cessing time, imaging systems and procedural costs 3. Other key challenges include sampling time,
limited tissue that can be stained due to time and cost involved consequently resulting in evaluation
of only three 4 µm sections of tissue to represent a 1 mm diameter core. Irreversible dye stain-
ing of tissues leads to loss of precious biopsy samples that are no longer available for biomarker
testing. Automated, low-cost and rapid generative algorithms and methods that can convert native
nonstained whole slide images to computationally H&E stained versions with high precision can
be transformative by benefitting patients, physicians and to reduce errors and costs.
Whole-slide pathology images are United States Food and Drug Administration (FDA) ap-
proved 4 for cancer diagnosis, and can rapidly be integrated into machine learning and AI algo-
rithms for automatic detection of cellular and morphological structures to tumors and virtual stain-
ing 5. Studies testing operational feasibility and validation of results obtained by generative models
and machine learning algorithms in controlled clinical trials or hospital studies with whole-slide
pathology images do not exist, consequently precluding clinical deployment of these systems. As
examples, previously reported approaches for automated staining of tissue biopsy using partial im-
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ages or patches have constraints such as, a) requirement for prestaining tissues prior to excitation
with specific wavelengths of UV radiation; b) acquisition of specialized hyperspectral, fluorophore
tagged, multispectral images using costly systems; c) staining only few cellular components with
low accuracy and limited color spectrum; d) significant loss of information in the stained images;
e) limited clinical validation using coarse diagnosis from synthetic images; f) lack of computer
vision and image processing methods for benchmarking quality of generated images; and g) no
explanation of mechanisms, specifically when neural networks are used, for virtual staining.
We previously communicated convolutional neural networks for learning associations be-
tween expert annotations of disease and fluorescent biomarkers manifested on RGB images and
their complementary non-fluorescent pixels found on standard white light images 6. Subsequently,
we communicated Conditional Generative Adversarial Neural Networks (cGANs) that accept na-
tive nonstained prostate core biopsy RGB Whole Slide Autofluoroscence Images (RWSI) and com-
putationally H&E stain them by learning hierarchical non-linear mappings between image pairs be-
fore and after H&E dye staining 7. Another destaining model converted RWSI of H&E dye stained
prostate core biopsies into their native nonstained form 7. In this work, we report several novel
mechanistic insights and methods to facilitate clinical deployment and regulatory evaluations of
these systems. Specifically, large and diverse training datasets of images of deparaffinized prostate
core biopsy RWSI from patients with different grades of tumor were used to, a) train high fidelity,
explainable and automated computational staining and destaining algorithms that learn mappings
between naturally autofluorescent pixels 8 of nonstained cellular organelles and their stained coun-
terparts; b) devise robust loss function for our machine learning algorithms to preserve tissue
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structure; c) establish that our H&E staining neural network models generalize to accurately stain
previously unseen images acquired from patients and tumor grades not part of training data; d)
generate neural activation maps to provide first instance of explainability and mechanisms used by
cGANs models for H&E staining and destaining; e) establish computer vision analytics to bench-
mark the quality of generated images; and f) validate computationally stained images for prostate
tumor diagnoses with multiple MD pathologists for clinical deployment (Figure 1). By describ-
ing explainable algorithms that can consistently, rapidly and accurately computationally stain and
destain tissue biopsy RWSI, this study generates actionable evidence for clinical deployment, real-
world and regulatory evaluations for virtually stained H&E images and contributes to the fields of
clinical development, computer science, oncology and digital histopathology.
2 RESULTS
Patient metadata: Thirty-eight patients (mean age 66.2 years) consisting of White, African Amer-
ican, Hispanic/Latino, and Asian men provided forty-six core biopsy samples. Of these, nine pa-
tients had known prostate cancer diagnosis and were undergoing active surveillance. Eighteen
patients underwent subsequent prostatectomy and the remaining were either healthy or undergoing
prostate cancer treatment at Brigham and Womens Hospital. Each biopsy sample contained one
to six cores of tissue. Zero to 100% of each tissue core contained prostatic adenocarcinoma of
various Gleason grades. Samples were enriched for higher-grade tumors (Gleason grade 4 and 5).
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Quantitative evaluation of computationally stained and destained images: Computationally
H&E stained whole slide images were compared pixel-by-pixel to corresponding H&E dye stained
images (Table 1). Structural Similarity Index (SSIM), Peak Signal to Noise Ratio (PSNR)-calculated
usually in logarithmic (dB) and Pearsons Correlation Coefficient (PCC) were used as quality
measures of computationally stained images with H&E dye stained images regarded as ground
truth 9, 10. Average SSIM of 0.902 (max=1), and PSNR of 22.821 dB were calculated, indicating
high accuracy of computational H&E staining of test images (Table 1). High PCC accuracy scores
(81.8% of patches with PCC ≥0.7 and 39.4% patches with PCC ≥0.8) indicate that computation-
ally stained patches matched H&E dye stained patches at a pixel level (Table 1).
Comparison of Red (R), Green (G) and Blue (B) color channels pixel intensities between
native nonstained and computationally stained images (-42px Table 2: U C), and those between
native nonstained and H&E dye stained images (-44px Table 2: U H) show that computationally
stained images had mean intensity difference of only 2px (Table 2: H C). Similar low differences
(underlined) were observed after comparing individual color channels: R (Supplementary Table∗
(ST) 1:U C=-58px, U H= -58px, H C=0px), G (ST 2: U C=-6px, U H= -8px, H C=2px) and B
(ST 3: U C=-62px, U H= -65px, H C=3px) between ground truth H&E dye and computationally
stained images.
Prostate core biopsy H&E dye stained images were computationally destained and compared
to native nonstained images as described above. Average PCC, SSIM and PSNR across our test
∗Supplementary tables are in Supplementary Material.
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images after destaining were 0.9, 0.963 and 25.646 dB respectively (Table 1), thus showing high
similarities with native ground truth nonstained images. RGB pixel intensities between compu-
tationally destained and H&E dye stained images (47px Table 2: H D), and native nonstained
and H&E dye stained images (44px, Table 2: H U) also indicated that computationally destained
and ground truth nonstained images only had 3px difference in their overall intensities (Table 2:
D U). These results indicate high fidelity of learning, reproducing and erasing of multi-chromatic
information by computational H&E staining and destaining algorithms. Average change in pixel
intensities in the R and B channel was higher compared to the G channel because H&E dye pre-
dominantly consists of blue and red/pink colors.
Analyses of physician annotations: United States medical board certified/trained pathologists
examined dye stained or computationally H&E stained images generated by neural networks (ad-
ditional details in methods section) for prostate tumor diagnoses. Both sets of physicians were
not told the source of images provided to them or the details of the study. Another independent
pathologist ratified diagnoses and tumor labels provided by both sets of reviewers and compared re-
sults to patient records (Figure 1). Intersection over union indicating agreements or disagreements
between pathologists examining the same set of images (intra-IOU) was calculated by pixel-by-
pixel comparisons of their tumor and non-tumor annotations (ST 4). Pathologists examining H&E
dye stained images had high average intra-IoU agreement scores (IoUH&E dye stained=0.81) for di-
agnosing any tumors (ST 4). Pathologists examining computationally H&E stained images also
had high and comparable average intra-IoU agreement scores (IoUcomputationally stained=0.77) for di-
agnosing any tumor (ST 4). These results indicated high internal consistency in clinical diagnosis
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provided by each set of pathologists on their respective images. Furthermore, tumor diagnoses us-
ing computationally stained images did not have an impact on rater sensitivity or specificity while
detecting tumors.
Tumor labels provided by two sets of physicians in our single-blind study on ground truth
H&E dye stained images or computationally stained images were then compared using inter-IoU
agreement score metric 11 (Table 3). An overall inter-IoU score of 0.79 was calculated for any
tumor diagnoses. An average inter-IoU agreement score of 0.70 was calculated for Gleason grade
3 labels, while scores of 0.73 and 0.64 were calculated for Gleason grade 4 and 5 labels (Table 3).
Average inter-IoU agreement score of 0.90 was calculated for annotations of healthy areas in the
tissue where no tumors were found on images (Table 3). For example images in Supplementary
Figure∗ (SF) 3 and 12 were entirely benign and both sets of reviewers did not annotate tumor
labels on these images. These results indicate that our trained machine learning models can ac-
curately generate both tumor and non-tumor signatures via H&E staining. And physician raters
showed concordance and comparable sensitivity and specificity in diagnoses made using H&E dye
stained with those made by using computationally stained images.
Clinical evaluations of computationally stained images: Figure 2 shows representative input
nonstained image patches in row (a) that had Gleason grade 3 (columns I, II) or 4 (columns III, IV)
tumors or were benign (column V), and their computational H&E staining (row c) and accuracy
calculated using annotations by multiple physicians (row d). Tissue morphology in computation-
∗Supplementary figures are in Supplementary Material.
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ally stained patches (Figure 2: row c) matches closely with H&E dye stained patches (Figure 2:
row b). Patch c-I successfully generated a benign area along with tumor signature (as indicated
by arrows) and confirmed in Figure 2: row d-I. Computationally stained patches (Figure 2: row
c) retain appearance of benign and malignant glands and stroma seen in H&E dye stained patches
(Figure 2: row b). Patch b-III also contains edge/crush artifact (arrowheads) that is preserved in
computationally stained image (Figure 2: row c-III). Figure 2: row d shows same patches with
color-coded areas of agreement and disagreement between the labels provided on H&E dye stained
images and computationally stained RWSI. It is evident that the computationally H&E stained
patches represent tumor signatures with high accuracy and pathologists are able to correctly iden-
tify tumor. Majority of observed disagreements between raters did not represent misidentification
of glands as benign or malignant. Instead, they show differences in rater annotation at borders of
tumor labels, mainly due to differences in labeling style with some raters providing course labels
and others annotating detailed labels (Figure 2: row d-III, arrows), or biopsy edges, as some
raters chose to score partial/crushed glands at the periphery of samples and others did not (Figure
2: row d-III, arrowheads).
Reconstructed computationally stained images shown in SF 1b and 2b (used for validation of
the trained neural network) morphologically represented benign and malignant glands and stroma
well enough to be consistently identified by pathologists (SF 1c and 2c) when compared with
corresponding H&E dye stained images (SF 1a and 2a). A vast majority of tumor also showed
annotator agreement. In some instances, “atypical” glands that were morphologically indetermi-
nate for malignancy led to interpretative discrepancies however showed preserved morphology in
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the computationally stained images (e.g. arrows in SF 1a and 1b). Ground truth nonstained (SF
1d and 2d) and corresponding computationally destained images (SF 1e and 2e) are also shown
for comparison.
SF 4b, 6b and 7b, show the most reported areas of disagreement many of which are at-
tributed to atypical glands that were hard to categorize on both images but were well represented
on the computer-generated images (SF 4c, 6c and 7c). SF 5 shows the uncommon Gleason pat-
tern 5 tumors with comedo necrosis (SF 5a, arrow). The morphology of the tumor glands is well
maintained (SF 5b, arrowheads), but the comedo necrosis is not visualized (SF 5b, arrow). The
dye-stained image in SF 7a contains an infrequently encountered scenario (indicated by an arrow),
the presence of rare malignant glands that are not well visualized on the computationally stained
image (SF 7b, arrow). Despite this altered appearance, there was no impact on clinical diagnosis
as the blinded reviewers scored these areas as tumor. Some glands are poorly formed on both
the dye stained and the computationally stained image (SF 8a, 8b, arrows), leading to disagree-
ment between raters, even though the computationally stained image were identical to dye stained
image.
Images shown in SF 9 presented a challenging labeling exercise where tumor cell cytoplasm
was very pale and did not show significant contrast to the background stroma in the dye-stained
image (SF 9a). This cytoplasmic pallor was also well preserved in the computationally stained
image (SF 9b). Despite this, appearance of the nuclei and the slight difference in cytoplasmic
texture made the tumor identifiable in both images (SF 9c and 9d). The computationally stained
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images shown in SF 10b, 11b and 13b were well represented. Majority of the disagreement in
these images arose due to tumor/non-tumor boundary and biopsy edge issues. Validation images in
SF 11b and 13b illustrated additional high-quality examples of preserved morphology generated
by the computationally staining algorithm, which confirmed accurate matching with dye stained
images in benign conditions. Non-necrotizing granulomas, marked chronic inflammation, reactive
stromal changes and proteinaceous debris were all morphologically identifiable in the computa-
tional stained images (SF 11c). Pathologists unanimously scored the matched H&E dye stained
and computationally stained images shown in SF 3 and 12 as benign.
SF 14 shows additional examples of indeterminate atypical glands (columns I and II) and
tumor with edge/crush artifact (columns III and IV) that are well preserved on the computationally
generated images but differentially designated as tumor or non-tumor by raters. SF 14 column
V shows non-necrotizing granulomas (arrows in c-V), which represent the only example of this
feature in our training and validation sets. Despite not being encountered before, the morphology
of the granulomas was relatively well maintained, resulting in the correct identification by raters
and categorization as non-tumor.
Comparison with patient records: A vast majority of the diagnoses rendered using computation-
ally stained images agreed with the corresponding initial clinical diagnosis reported in Electronic
Health Records (EHR) (Table 4), supporting the validity of the generated images for tumor detec-
tion and diagnoses. Majority study cases showed identical tumor fractions and Gleason grading
as previously reported. After expert re-review of the original slides and additional evaluation by
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immunohistochemistry, the original EHR diagnosis was overturned in two cases, resulting in two
additional cases of agreement. Pathologists reviewing computer-generated core 11 were able to
better identify the presence of rare glands of Gleason grade 3 tumors than those who had rendered
the original EHR diagnosis of benign (SF 11 marked blue/green). Microscopic re-review of the
original glass slide confirmed that it indeed had a tiny focus of grade 3 tumor that was overlooked
at the time of the original diagnosis. Subsequent immunohistochemical analysis revealed the ab-
sence of basal cells around the glands in question, confirming the diagnosis of carcinoma made
during this study and revealing the diagnosis conferred on the computationally generated images
to be correct. SF 2 was the only study biopsy that showed a significant difference in tumor fraction,
as this study reported 50% tumor fraction and the original EHR report was 90%. Re-review of the
original glass slide again showed this study fraction to be more accurate than the original diagno-
sis (SF 2). Otherwise, the tumor fraction identified in all the computationally generated images
approximated the fraction reported in the EHR for all images as evident from Table 4.
None of the differences between EHR and computationally generated H&E diagnosis were
clinically significant with regard to treatment decisions. A difference in grade of tumor was iden-
tified in a minor component of computationally stained images (SF 4, 7 and 13). The small foci
of higher or lower grade tumor identified in computationally stained images (SF 4c, 7c, and 13c),
which were not reported at the time of original diagnosis, comprised a very small fraction of tumor
volume. These were often associated with diagnostically indeterminate questions (e.g. whether a
gland represented a rare focus of grade 4 tumor or if it was tangential sectioning of grade 3 tu-
mor), and were not clinically significant in the context of the patient’s known tumor at the time of
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original EHR reported diagnosis.
Analysis and explanation of neural network activation maps: Neural activation maps of trained
staining and destaining cGAN models were analyzed after feeding healthy (shown in Figure 2 row
a-V), Gleason grade 3 (Figure 2 row a-I), 4 (Figure 2 row a-IV) or 5 images patches. Majority of
previous research in explaining neural networks trained for image classification correlate and clas-
sify convolutional neural network activation maps kernels back to input images being analyzed 12.
In this work we do not use a classification approach to identify image features, but rather perform
pixel-by-pixel visualization, explanation and intensity ranking (>200 value) of various cGAN ker-
nels to create an activation map of a particular nonstained image patch (healthy or with a particular
Gleason tumor grade) as it passes through each network layer while getting stained (Figure 3). To
our knowledge, no prior study (other than the research in our laboratory 7) has described compu-
tational destaining of H&E dye stained images to revert them to their native nonstained form for
virtual staining with other dyes or for conversion to immunohistochemistry feature space. Compu-
tationally destained images in this study were also used to evaluate the activation profiles of trained
neural network H&E staining models (Figure 3).
We demonstrate and compare presence of unique low and high-level features in input images
(computational vs. dye stained for e.g.) that activate neurons and feature maps in the cGAN
generator network (Figures 4, 5 and 6). For example, initial layers of the convolutional layers
in the generator detect low-level features such tissue geometry, edges, corners, shapes and a few
changes in color (Figures 4 and 5, Layers L1, L2 & L3, panels I, III & V). We see well-
13
demarcated boundaries between tissues and background (Figure 4 and 5, Layers L1, L2 and
L3, panel I) and gross distinctions between glands and stroma are suggested (Figure 4, Layer
L2, panel I) or are well defined (Figure 5, Layer L1, panel I). A high amount of activation in
background pixels of the image (not containing tissue) was observed in majority of panels in layers
L1 to L5 (Figures 4 and 5). Panel I in layers L1 and L3 in Figures 4 and 5 show an excellent
example of activation of neural network kernel switching between focusing most significantly on
the background (Panel I in layer L1) vs. another kernel almost exclusively being activated in
response to tissue (Panel I in layer L3). Kernels of initial layers of trained models thus help with
differentiating tissue from background and morphological tasks to define higher order anatomical
structures (Figures 4 and 5).
The later convolutional layers leverage previously learned low level features and ability to
differentiate tissue from background with fine-grained structures such as anatomical arrangement
of nuclei and tumor signatures (Figures 4 and 5, Layers L17, L18 and L19). For example, maps
in layers L17 in Figures 4 and 5 illustrate that the neural network activation profile is significantly
minimal for background, morphology and shapes but rather responsive to fine grained microscopic
features contained in the tissues. Significant activation is also seen in boundaries separating stroma
from glands, whether benign or malignant (Figure 5, Layer L17, L18 and L19). SF 16 and 17
show additional examples activation maps of images of prostate core biopsy with Gleason grade 4
and 5 tumors which demonstrate similar activation patterns, suggesting a conserved mechanism is
used by trained generator to perform computational staining across tumor grades.
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We compared kernel activation maps of all 448-validation image patches used to test our
trained staining and destaining machine learning models with corresponding ground truth dye
stained and native nonstained images (Figure 6). Mean-Squared Error (MSE) was calculated by
comparing activation maps generated by each of the 19 neural network layers in response to pairs
of images being evaluated. Translucent blue lines show the MSE for all the 448 input patches. The
red line shows that the average MSE was very low and max average NMSE is less than 0.0005.
Figure 6a shows that native nonstained images and corresponding computationally destained input
images activated our trained computational staining neural network layers with high similarities
while being stained. We also calculated similar low MSE (Figure 6b) in activation maps when
computationally stained and corresponding H&E dye stained images were fed to our trained com-
putational destaining model. MSE was low for 1st layer, increases for 2nd layer and then decreases
for the remaining layers. The MSE peaks for layers 3, 10 and 17 were slightly higher suggesting
unique activation patterns were more prevalent in kernels residing in these layers. These results,
in unification with our detailed SSIM, PSNR, CC and physician validation, provide significant
evidence of high quality of computationally stained and destained images, with consequent high
sensitivity and specificity in diagnosing tumors using them.
3 DISCUSSION
A vast majority of surgical and medical treatments for cancer, including chemotherapy, en-
docrine therapy, and immunotherapy are dictated by histopathologic examination and diagnosis.
Increase in use of core biopsies for diagnosis, in place of larger surgical biopsies, has resulted in
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significant decrease in the volume of tumor available for performing an ever-increasing battery of
biomarker testing for diagnostic, prognostic, and predictive information. If a new process to obtain
an instant and accurate computational H&E staining of native nonstained WSI of prostate tissue
is developed, it will accelerate process of conventional histopathology and save precious tissue
samples.
Computationally stained and destained images reported in this study were evaluated by mul-
tiple image analytics and matched ground truth images with high similarity (Table 1). MSE com-
pares the true pixel values of H&E dye stained images to computationally stained images and is
inversely correlated to PSNR 9. Thus, higher the PSNR, the better computationally stained image
has been reconstructed to match the original image and the superior the H&E staining or destaining
algorithm. The main limitation of PSNR is that it relies strictly on numeric pixel comparison and
does not account for biological factors of the human vision system that detect macro structures 9.
Unlike PSNR, SSIM is based on visible structures in the image with the notion that pixels have
strong inter-dependencies especially when they are spatially close 10. These dependencies carry
important information about the structure of the objects such as tumors, stromas, and glands and
other morphological tissue feature in the H&E images. Whereas PCC test is performed by ran-
domly scrambling the blocks of pixels (instead of individual pixels, because each pixel’s intensity
is correlated with its neighboring pixels) in H&E dye stained image, and then measuring the cor-
relation of this image with the computationally stained image 13. Taken together, high quality of
the computationally stained and destained images calculated using MSE, PSNR, SSIM and CC cu-
mulatively provided comprehensive and stringent evaluation of their macroscopic and microscopic
16
suitability for clinical deployment.
Evaluation by trained pathologists showed tumorous and healthy tissues were morpholog-
ically well represented in majority of the computationally stained images with high accuracy
(Figure 2 and SF 1-13). The glands and stroma of benign prostatic tissue and carcinoma were
identifiable, showing preserved architectural features (location and shape of the glands), defined
gland/stromal interface, and cytology (including location and appearance of the nuclei and nucle-
oli, if present). A majority of the differences in annotations (such as those seem in SF 4 and 13)
were observed either on the tumor/non-tumor interface/boundary or the biopsy boundary. This can
be attributed to labeling style of individual raters, where some raters gave detailed labels while the
others gave course labels and some chose to label crushed glands at the periphery of the tissue.
Previous studies report that human readers show substantial variability and lower average perfor-
mance than computer algorithm in terms of tumor segmentations 14. Similar limitation of using a
human reader panel to establish a reference standard for evaluation of computer algorithms may
have impacted this study. In validation images, presence of morphologically ambiguous glands, a
known histopathologic dilemma that clinically requires additional work up for confident diagnosis,
also led to differing labels between raters as they were asked to categorize each gland as benign
or malignant without assistance from supplemental studies. In most cases (SF 8) these ambiguous
cases were well represented in the computationally stained images (arrows in SF 8b), but led to
labeling differences due to the ambiguity of these said regions of interest (ROI).
Small difference calculated by PSNR, SSIM, CC (Table 1), independent of the human raters,
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may also be in-part due to registration differences in small out-of-focus areas during WSI 15. Input
image pairs (nonstained and H&E stained) used for training in our work were corrected for dif-
ferences in field of view, illumination and focal planes but may still have minor variances. These
small variances in computationally stained images though had no impact on overall clinical assess-
ments. Color variations in digital slides may arise due to differences in staining reagents, thickness
of tissue sections and staining protocols and can negatively impact clinical diagnoses 5. We report
minimal color variation across our 13 computationally stained H&E images as seen by their uni-
form overall RGB and individual R, G and B channel intensity values which often match training
images (Table 2, ST 1, 2 and 3). Physician raters in the study did not report difficulty in reading
colors of nuclei, glands, cells and tumors in computationally stained images, which was ratified
by an additional independent pathologist. Thus, the trained neural network model reproduces a
consistent and normalized color hue from the vast training dataset that does not impact clinical
decision making from computational images. And the subsequent absence of false-positive errors
in healthy tissue cores of patients illustrates the fine grain reproduction of our computationally
stained and destained images.
We were also pleased to find high concordances between diagnosis made using the compu-
tationally stained images in this study and patient EHR (Table 4). We in fact found two instances
where the diagnoses made using computationally stained images overturned the initial EHR find-
ings. In both cases, additional laboratory tests and clinical workups were performed to confirm our
findings. These results demonstrated that raters and the tumor diagnoses performed using com-
putationally stained WSI used in our study matched or exceeded the initial microscopic diagnosis
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performed using H&E stained tissue slides after prostate biopsy extraction.
Virtual staining of histopathology slide images has been reported using approaches with sig-
nals that require long detection times 16, dye staining of nonstained specimens prior to imaging 17,
laser illumination and excitation with specific wavelengths 18 and sparse sampling and poor depth
resolution 17, 19. Previous virtual staining studies have performed limited analytics 20 to benchmark
the quality of their virtually stained images. Majority do not perform pixel level comparisons with
ground truth images and use small numbers of non-blinded raters who use coarse annotations, with-
out tumor gradations 21, 22. While others report no clinical validation and benchmarking of their
results 23–25. Another recently published study required prestaining tissues with eosin, rhodamine
and several other dyes before imaging with multiple UV wavelengths to generate autofluorescence
images, which were then evaluated by a single pathologist 17. In summation, these techniques
and studies have shown limited spatial resolution to locate small tumors, suffer from auto fluo-
rescence and specular reflections issues, required prestaining or specialized illumination sources,
fluorescence scopes and sensors and/or conduct limited image quality or clinical evaluations.
Similarly, previous deep learning research for virtual staining uses specialized illumination
sources and does not report robust validation studies on mechanisms to establish computer vision
or diagnostic utility of generated images 5. Bayramoglu et. al. virtually stain lung tissue slide
multispectral images with a cGAN and achieve a structural similarity (SSIM) of 0.3873 but per-
form no clinical validation 26. Bulingame et. al. use cGAN to convert H&E stained pancreas
slide RGB images to immunofluorescence images and achieve a SSIM of 0.883, and also do not
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report clinical validation of generated images 27. Rivenson and coworkers use a fluorescence scope
with specialized UV filters to capture various tissue biopsy images and virtually H&E stain them
using a neural network 28. Results and findings communicated in our study differ from previous
deep learning based virtual staining studies in several key aspects. As examples, Rivenson et.al.
utilized a wide field fluorescence microscope to image tissue 28 vs. the non-fluorescent mode of
a FDA cleared and widely available automated slide scanning system to capture images used in
our study. A single pathologist compared anatomical features between virtually stained images
using coarse labels, and pixel-level comparisons between tumor labels on virtual and ground truth
images or concordance with EHR of patients were also not conducted to calculate true and false
positive occurrences of tumor diagnoses reported in that study 28. Computational destaining of
tissue images and stringent image analytics such as PSNR or CC to benchmark quality of virtually
stained images have not been reported in previous deep learning based studies 26–28. Analysis or
visualization of key neural network kernels and image features that get activated during the stain-
ing process have not been, and thus precluding mechanistic insights or mathematical validation of
previous findings reported in literature 26–28.
In this study, we communicate trained neural network models that computationally H&E
stain native unlabeled RGB images of prostate core biopsy (acquired without band pass filters or
specialized hardware) with anatomical features of prostate and reproduce cancer tumor signatures
with high accuracies. Computational pixel-by-pixel analysis and comparisons using PSNR, SSIM
and PCC demonstrate high similarities between our computationally stained images and their H&E
dye stained counterparts. Pixel-by-pixel changes in R, G, and B color channels after computational
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staining and destaining by neural networks match corresponding changes in RGB intensity when
native nonstained images are H&E dye stained in pathology labs vice versa. Detailed clinical
validation in a single blind-study found high inter and intra-rater agreements, calculated by pixel-
by-pixel analyses of tumor labels provided by multiple board certified/trained physicians. Compu-
tationally stained images thus accurately represented healthy tissue as well as tumors of different
Gleason grades, which were easily detected by human visual perception. Clinical diagnoses made
using computationally stained images in our study were consistent with tumor diagnoses reported
in EHR. We investigate layers of generator neural networks and calculate activation of kernels dur-
ing staining of different prostate tumor grades and benign tissue signatures to visualize and explain
the process of computational H&E staining and destaining. Activation maps of our trained neural
network models during computational staining or destaining of test images were highly similar
to H&E dye stained or native nonstained images. Thus by visualizing and comparing activation
feature maps of kernels of trained models this work also presents the first explainable deep neural
network framework for computationally H&E staining or destaining of native RGB images.
This study provides framework for generating actionable and explainable evidence for regu-
latory evaluations prior to conducting controlled clinical trials for establishing efficacy of Artificial
Intelligence algorithms as clinical support systems 29–31. We also communicate foundational work
for adopting computational H&E staining methods in clinical environments for enabling saving of
time and effort required for manual staining and slide preparation, and more importantly preserva-
tion of precious tissue samples which could be used in a targeted fashion for biomarker evaluation.
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4 METHODS
Data collection, transfer and processing of whole slide images: Partners Human Research
Committee (Boston, MA) approved protocol 2014P002435 ***********, after which excess ma-
terial from prostate core biopsies performed in the course of routine clinical care between 2014
and 2017 at Brigham and Women’s Hospital (BWH), Boston, MA, were obtained for this study.
Forty-six non-stained and corresponding H&E dye stained RWSI were collected from 38 patients
and imaged at 20x magnification. Briefly, prostate core biopsy specimens were immediately fixed
in 10% formalin, paraffin embedded, cut into 4-micron thick sections and placed on standard glass
slides that were placed in archival storage at room temperature. Deparaffinized nonstained slides
were scanned with the Aperio ScanScope XT system (Leica Biosystems, Buffalo Grove, IL) at 20x
magnification. Subsequently, slides were stained with H&E dye on the Agilent Dako Autostainer
(Agilent, Santa Clara, CA), and these stained slides were re-scanned on the Aperio ScanScope XT
at 20x magnification at Harvard Medical School Tissue Microarray & Imaging Core. Deidentified
data in the form of nonstained and H&E dye stained images at 20x magnification were analyzed at
Massachusetts Institute of Technology. Individual prostate tissue needle core biopsy images from
each whole slide image were extracted. Extracted core images were horizontally or vertically ro-
tated to reduce non-tissue pixels. This resulted in 102 high-resolution native nonstained and H&E
dye stained image pairs.
Image registration and processing: Deparaffinized single core images (henceforth called as non-
stained images) and subsequent H&E dye stained single core images of the same biopsy (hence-
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forth called as H&E dye stained images) were registered using Photoshop CC software (Adobe
Systems, San Jose, CA) and corrected for variances 32, 33. Tissue shearing during the staining
procedure resulted in regions that could not be registered that were cropped and discarded.
Training and validation datasets: The registered dataset of images was divided into training (82
image pairs) and validation images (13 image pairs). The final patch based training and validation
dataset consisted of 74K (training) and 13.5K (validation) image patches. Validation and training
datasets were balanced to include images from healthy patients as well as patients with different
grades of prostate tumors and of each tumor grade. The size of the RWSIs were too large to
feed into deep learning networks, therefore each image was cropped into multiple patches of size
1024×1024×3 pixels.
Machine learning model architecture: A cGAN pix2pix based model was trained to learn dis-
tribution and mappings between registered images in the training dataset 34. The trained model
can accept native nonstained images and generate corresponding computationally H&E stained
images via the learnt feature space. If Iu and Is represent the native nonstained and H&E stained
image patches in the training dataset. The generator takes in Iu as the input and generates Ics,
the corresponding computationally stained image patch, as the output. The discriminator analy-
ses the output image Ics and predicts the probability that Ics is real (from the training dataset) or
fake (output from generator). While training, the generator learns to create images, which can
fool the generator while the discriminator learns to correctly identify the fake images. The gener-
ator and the discriminator thus play a min-max game trying to outlearn each other. A novel PCC
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term was devised specifically for training our neural network models that was added to the cGAN
loss function to improve the quality and enforce tissue structure preservation of computationally
stained images. The loss function consisted of the cGAN loss 11, a L1 component and a PCC
factor between Is and Ics. The PCC term in the loss function help reduce the tiling artifacts in the
computationally stained images. The loss equation was :
LcGAN(G,D) = Ex,y[logD(x, y)] + αEx,z[log(1−D(x, G(x, z)))]
LL1(G) = Ex,y,z[‖ y −G(x, z) ‖1]
LPCC(G) = Ex,y,z[PCC(y, G(x, z))]
The final loss function is:
G∗ = arg min
G
max
D
LcGAN(G,D) + λLL1(G) + γLPCC(G)
where x is the input image, y is the target image and z is the random noise, added as dropout in
our work. LcGAN(G,D) is the cGAN loss function, LL1(G) is the L1 loss between the output of
the generator and the target image, and LPCC(G) is the proposed term that calculated the Pearsons´
correlation coefficient between the generator output and target image. α = 1, λ = 100 and γ = 10
gave best results. After training, the model accepted unseen native nonstained image patches and
generated computationally H&E stained images patches.
Training and validation of machine learning models: Two machine learning models were trained
a staining model that generates computationally H&E-stained RWSI patches using previously un-
seen non-stained and native RWSI patches as input, and a destaining model that reverses the pro-
cess and computationally destains previously unseen H&E dye-stained RWSI patches. Both mod-
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els were trained using 74K patches and validated on 13.5K patches. The discriminator was trained
after every single training step for the generator. Both networks were trained for 10 epochs each us-
ing Adam optimization 27, and a batch size of one on a NVIDIA GeForce 1080 TI GPU (NVIDIA,
Santa Clara, CA) with 12 GB of VRAM and CUDA acceleration to speed up training. One epoch
of training (74K training patches) took approximately 16 GPU hours. The patches were randomly
flipped and dropout was used to prevent over-fitting and increase generalization capability of the
model.
Evaluation metrics: The computationally stained image patches Ics, generated by our model
were compared to the H&E dye patches Is to obtain a quantitative measure of the generated images.
PCC, PSNR and SSIM were used to quantify similarities and differences between a given pair of
images at a pixel level. The values of PCC and SSIM ranges from 0 to 1, higher values are better.
Acceptable values of PSNR for wireless transmission quality loss are considered to be between
20dB to 25dB. Higher PSNR is better. The average and total increase in pixel intensity after
computationally staining and destaining was calculated by subtracting the mean pixel intensity of
the second image from the first.
Clinical validation of computationally H&E stained RWSI: Clinical diagnoses by five physi-
cians to investigate, compare and evaluate the efficacy of computationally stained images for tu-
mor diagnoses was conducted. Computationally stained patches from the validation set were used
to create reconstructed RWSI images. The corresponding RWSI H&E dye stained images were
used as ground truth examples and also labeled for tumors. A single blind study was conducted
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for evaluation of generated images in clinical settings for prostate cancer diagnosis. Four board
certified/trained expert pathologists provided detailed labels in the forms of free-form outlines en-
compassing tumors, indicating tumor regions (with grade) and other atypical manifestations on
the computationally stained images and H&E dye stained image. In the first round, two randomly
selected pathologists were provided computationally stained images while H&E dye stained im-
ages were given to the other two raters. After a period of four weeks the image sets were swapped
between the pathologists, and another round of annotations were conducted. Pathologists anno-
tated images in the form of free hand drawing using the Sedeen Viewer (PathCore Inc., Toronto,
Ontario, Canada) on identical notebook computer screens (Dell Computers, Round Rock, TX). By
using different colors corresponding to each tumor grade, annotations were classified with tumor
grade - Gleason grade 3 (G3), Gleason grade 4 (G4), Gleason grade 5 (G5). A separate comments
box was used to note other clinical observations and for anatomical features. The annotations and
the associated labels (G3, G4, G5) were extracted from the XML files generated by Sedeen, using
the labels and annotations using Python code. ater agreement was calculated in the form of IoU
by using the overlap in rater annotations on computationally stained and corresponding H&E dye
stained images 11. A fifth physician was provided computationally stained and H&E dye stained
image pairs leaded in Sedeen to perform qualitative comparisons for histologic structures and fea-
tures. The final tumor labels on the H&E dye stained images and corresponding computationally
stained images were ratified by an independent clinical pathologist. Accuracies and errors were
calculated using pixel-by-pixel overlap in the labels. Color-coded error overlaid validation images
were generated visualizing the true positives (green), false positives (red) and false negatives (blue)
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(SF 1-13).
Activation maps: Input images containing Gleason grade 3, 4 and 5 signatures were fed into
our trained computational staining network to visualize activation maps for each input image.
RWSI (full scale RGB images at 20x resolution) were collected/constructed for the following eight
image datasets (four pairs) each with 13 images: [Ground] Native nonstained; [Ground] H&E dye
stained; [Predicted reconstructed] Computationally stained; [Predicted reconstructed] Destained
(also referred to as predicted destained images). 448 unique patches in each of the eight datasets
with no overlap were created for each of dataset and set to size 1024×1024×3 (3 color channels).
For each matching patch pair to be fed into computational staining or destaining models, we go
linearly over the grid and isolate consolidated activation maps from layer 1 to layer 19 (shown
in Figure 3). A script code (pix2pix activation analysis.py) 34 created individual activation
maps per layer of the model architecture that are resized to a fixed size (128×128 pixel), and then
concatenated together to form a single image per layer of the model architecture. An example
concatenated activation map can be seen in Figures 4 and 5. Each image contains 64 activation
maps that have been concatenated together. Normalization of the grayscale grid activation maps
to 0 to 1 by dividing each pixel by 255 (maximum value of any pixel) was done to dial the MSE
value down from 65,025 to 1.0. i.e. the upper bound on the resulting MSE is 1.0. MSE was
calculated using sklearn.metricsmean squared error API function. MSE values for all layers
(between the matching patch pairs) were collected in a list (array) and plotted on a graph using
matplotlib.pyplot library. The y-axis (MSE value) ranges from 0 to 1.0 and the x-axis (layer ID)
ranges from 1 to 19 (Figure 6).
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Figure 1. Overview of process of Computational staining and destaining of whole slide prostate
core biopsy images with Conditional Generative Adversarial Neural Networks (cGAN) shown on
left vs. traditional staining with Hematoxylin and Eosin (H&E) dyes using physical prostate core
tissue biopsy slides (right) and clinical evaluation by multiple physicians of images for tumor
diagnosis (left and right) described in this study.
Figure 2. Representative image patches generated by the computational staining neural network
and their comparison with corresponding ground truth Hematoxylin and Eosin (H&E) dye stained
images. Row (a) shows deparafinized native nonstained image patches fed to the neural network.
Row (b) shows ground truth H&E dye stained patches. Focal crush/edge artifact in b-III is in-
dicated by arrowhead. Row (c) shows computationally H&E stained patches generated by the
neural network. Arrows in c-I indicate the two benign glands, all other glands represent tumor.
Row (d) shows computationally H&E stained patches overlaid with colors indicating agreements
and disagreements between physician annotations on these images compared to ground truth H&E
dye stained images. Crush/edge effect (arrowheads) and variation in labeling detail by annotators
(arrows) are shown in d-III. Green is true positive, blue is false negative and red is false positive.
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Figure 3. Visualization and explanation of computational Hematoxylin and Eosin staining process
by custom auto-encoder neural network used in this study. Panel (a) Processing of native non-
stained prostate core biopsy images as various layers of the encoder and decoder neural networks
computationally stain them. The blue boxes represent hidden activation layers of the neural net-
work. Panel (b) A single input native nonstained patch and representative concatenated activation
maps (from the corresponding hidden layers in panel (a) of kernels of the decoder neural network
as it flows through them, are shown.
Figure 4. Activation maps of kernels of trained generator neural network model layers after feed-
ing a native nonstained prostate core biopsy image patch without tumor as it gets computationally
Hematoxylin and Eosin stained. Rows show top five activation maps from layers L1 - L5 and L16
- L19 arranged in decreasing order of their activations from left to right (columns I-V).
Figure 5. Activation maps of kernels of trained generator neural network model layers after feed-
ing a native nonstained prostate core biopsy image patch with Gleason grade 3 tumor as it gets
computationally Hematoxylin and Eosin stained. Rows show top five activation maps from layers
L1 - L5 and L16 - L19 arranged in decreasing order of their activations from left to right (columns
I-V).
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Figure 6. Comparison of Mean Squared Errors (MSE) between kernel activation maps of pairs of
448 validation image patches generated by the trained neural network models. (a) MSE of ground
truth native nonstained and corresponding computationally destained input patch activation maps
generated by the trained computational staining model; (b) MSE of computationally Hematoxylin
and Eosin (H&E) stained and corresponding ground truth H&E dye stained matching input patch
activation maps generated by the trained computational destaining model. Blue lines represent
the MSE values for each of the 448 input pairs. Red curve represents average MSE value at each
layer of the generator for all input pairs. The green and orange curves represent the first and third
quartile MSE values for all input patch pairs. Lower MSE indicates more accuracy between the
activation maps being compared.
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Image
Computational staining Computational destaining
PCC SSIM PSNR PCC SSIM PSNR
1 0.950 0.860 20.563 0.951 0.853 23.486
2 0.952 0.891 22.387 0.965 0.895 25.706
3 0.949 0.860 20.683 0.964 0.866 24.871
4 0.957 0.929 22.870 0.968 0.936 27.469
5 0.960 0.947 24.838 0.970 0.949 21.194
6 0.955 0.914 22.903 0.957 0.914 25.285
7 0.960 0.881 22.486 0.938 0.865 21.863
8 0.968 0.931 24.132 0.959 0.927 26.164
9 0.978 0.890 23.411 0.968 0.874 24.165
10 0.956 0.913 23.177 0.967 0.927 27.359
11 0.972 0.907 23.945 0.984 0.899 26.792
12 0.975 0.902 23.200 0.963 0.899 24.957
13 0.965 0.899 22.074 0.970 0.900 26.082
MEAN 0.961 0.902 22.821 0.963 0.900 25.646
Table 1: Performance analytics of computational staining and destining: Comparison between
computationally stained and ground truth Hematoxylin and Eosin (H&E) dye stained images, and
between computationally destained and ground truth native nonstained images. Pearsons Corre-
lation Coefficient (PCC) of 1.0 means perfect match; Structural Similarity Index (SSIM) of 1.0
means perfect match. Peak Signal to Noise Ratio (PSNR) of 22 dB or more is considered high
quality.
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Computational staining Computational destaining
Image U C U H H∗ C H D H U D U∗
1 -42 -43 1 45 43 -3
2 -30 -26 -4 37 26 -11
3 -39 -47 8 40 47 7
4 -48 -49 1 48 49 1
5 -48 -44 -3 44 44 0
6 -32 -34 2 44 34 -10
7 -19 -21 1 32 21 -12
8 -53 -53 0 58 53 -5
9 -45 -48 3 56 48 -8
10 -42 -40 -2 44 40 -4
11 -43 -42 -2 48 42 -6
12 -56 -66 10 62 66 4
13 -50 -58 8 56 58 2
MEAN -42 -44 2 47 44 -3
Table 2: Average pixel intensity differences following computational staining and destaining: Dif-
ference between Native nonstained and computationally stained (U C); native nonstained and H&E
dye stained (U H); ground truth H&E dye stained and computationally stained (H* C); H&E dye
stained and computationally destained (H D); H&E dye stained and native nonstained (H U); com-
putationally destained and ground truth native nonstained (D U*). All values are in pixel intensities
(0 to 255) calculated by subtracting the 2nd from 1st image. Positive values indicate decrease in
average pixel intensities and negative values indicate gain. Values have been rounded to nearest
integer. H is H&E dye stained image, C is computationally stained image, D is computationally
destained image and U is native nonstained image. Ground truth images are indicated with ‘*’ to
facilitate comparisons with computational images when necessary.
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Image Any tumor Healthy G3 G4 G5
1 0.90 0.96 0.90 - -
2 0.86 0.55 - 0.78 -
3 - 1.00 - - -
4 0.92 0.89 0.76 - -
5 0.52 0.90 - 0.49 0.64
6 0.80 0.93 0.58 - -
7 0.70 0.94 0.53 - -
8 0.79 0.92 - 0.77 -
9 0.58 0.96 0.48 - -
10 0.86 0.86 0.70 0.72 -
11 0.92 0.99 0.92 - -
12 - 1.00 - - -
13 0.93 0.78 - 0.89 -
MEAN 0.79 0.90 0.70 0.73 0.64
Table 3: Intersection over union (IoU) based agreement between pathologists for tumor signatures
provided using computationally stained images compared with those using ground truth Hema-
toxylin and Eosin (H&E) dye stained images. Any tumor: any tumor grade; Healthy: tissue
without tumors; G3: Gleason grade 3; G4: Gleason grade 4; G5: Gleason grade 5. ‘-’ indicates
that the tumor (or tumor grade) was absent on a particular image. Higher IoU score is better, with
a score of 1.0 representing perfect match of labels.
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Image Initial diagnosis after biopsy Diagnosis using computationally stained image
1 40% grade 3 tumor in core 40% grade 3 tumor in core
2 50% grade 3 tumor in core 90% grade 3 tumor in core ∗,†
3 Benign core Benign core
4 50% grade 3 tumor in core 50% grade 3 tumor (majority) with
traces of grade 4 tumor †
5 50% grade 4 and 5 tumor on core 50% grade 4 and 5 tumor on core
(G4 > G5) (G4 < G5) †
6 40% grade 3 and 4 tumor in core 40% grade 3 and 4 tumor in core
(G3 G4) (G3 G4) †
7 40% grade 3 tumor in core 40% grade 3 and 4 tumor in core
(G4 G3) †
8 40% grade 3 and 4 tumor in core 40% grade 3 and 4 tumor in core
9 20% grade 3 tumor in core 20% grade 3 tumor in core
10 90% grade 3 and 4 tumor in core 90% grade 3 and 4 tumor in core
11 Healthy core Tiny focus of grade 3 tumor in core ∗,†
12 Healthy core Healthy core
13 90% grade 4 tumor in core 90% grade 3 and 4 tumor in core
(G3 G4) †
Table 4: Comparison of tumor grades between original expert microscopic diagnosis [as reported
in the Electronic Health Records (EHR)] using the Hematoxylin and Eosin (H&E) stained glass
slide and the diagnosis of the computationally stained image. ∗ Agreements confirmed upon re-
review of the microscopic slide and additional supportive studies; † Not clinically significant within
the context of the patients known tumor.
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